His primary scientific interests are in Physical therapy, Internal medicine, Osteoarthritis, Surgery and Risk factor. His work deals with themes such as Clinical trial, Epidemiology, Arthritis, Randomized controlled trial and Disease, which intersect with Physical therapy. Rheumatology, Cohort, Incidence, Rheumatoid arthritis and Cohort study are the primary areas of interest in his Internal medicine study.
His Osteoarthritis study combines topics in areas such as Acupuncture, Guideline and Knee Joint. His study in Surgery is interdisciplinary in nature, drawing from both Alendronic acid, Relative risk, Confidence interval and Osteoporosis, Femoral neck. His research on Risk factor also deals with topics like
His primary areas of investigation include Osteoarthritis, Internal medicine, Physical therapy, Surgery and Osteoporosis. His work carried out in the field of Osteoarthritis brings together such families of science as Body mass index, Clinical trial and Radiography. His study looks at the relationship between Internal medicine and fields such as Placebo, as well as how they intersect with chemical problems.
His research investigates the link between Physical therapy and topics such as Epidemiology that cross with problems in Public health. Marc C. Hochberg has included themes like Celecoxib, Incidence, Confidence interval and Risk factor in his Surgery study. Osteoporosis is closely attributed to Orthopedic surgery in his work.
Marc C. Hochberg spends much of his time researching Osteoarthritis, Internal medicine, Physical therapy, Cohort and WOMAC. His Osteoarthritis research includes elements of Placebo, Clinical trial, Disease and Epidemiology. His Internal medicine research integrates issues from Gastroenterology and Surgery.
His Physical therapy research incorporates themes from Body mass index, Arthritis, Orthopedic surgery, Confidence interval and Prospective cohort study. His Cohort research focuses on Hip fracture and how it relates to Bone mineral, Dentistry, Gerontology, Cognition and Physical medicine and rehabilitation. His WOMAC study integrates concerns from other disciplines, such as Celecoxib and Severity of illness.
Marc C. Hochberg focuses on Osteoarthritis, Internal medicine, Physical therapy, WOMAC and Cohort. His Osteoarthritis research incorporates elements of Body mass index, Clinical trial, Randomized controlled trial, Placebo and Disease. His studies link Surgery with Internal medicine.
His Physical therapy research includes themes of Epidemiology, Alternative medicine, Hip osteoarthritis, Osteoporosis and Prospective cohort study. The study incorporates disciplines such as Patient satisfaction and Severity of illness in addition to WOMAC. His Rheumatoid arthritis study integrates concerns from other disciplines, such as Diabetes mellitus, Abatacept and Arthritis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
R. Altman;E. Asch;D. Bloch;G. Bole.
Arthritis & Rheumatism (1986)
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
Claire Bombardier;Loren Laine;Alise Reicin;Deborah Shapiro.
The New England Journal of Medicine (2000)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.
Reva C. Lawrence;David T. Felson;Charles G. Helmick;Lesley M. Arnold.
Arthritis & Rheumatism (2008)
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
Reva C. Lawrence;Charles G. Helmick;Frank C. Arnett;Richard A. Deyo.
Arthritis & Rheumatism (1998)
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
W Zhang;R W Moskowitz;G Nuki;S Abramson.
Osteoarthritis and Cartilage (2008)
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
Marc C. Hochberg;Roy D. Altman;Karine Toupin April;Maria Benkhalti.
Arthritis Care and Research (2012)
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
R. D. Altman;M. C. Hochberg;R. W. Moskowitz;T. J. Schnitzer.
Arthritis & Rheumatism (2000)
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip.
R. Altman;G. Alarcón;D. Appelrouth;D. Bloch.
Arthritis & Rheumatism (1990)
American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Kenneth G. Saag;Gim Gee Teng;Nivedita M. Patkar;Jeremy Anuntiyo.
Arthritis Care and Research (2008)
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.
M C Hochberg;R D Altman;K D Brandt;B M Clark.
Arthritis & Rheumatism (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: